Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Heer Pharma is an Indian pharmaceutical company headquartered in Mumbai that specializes in the manufacturing and export of finished dosage formulations and active pharmaceutical ingredients. The company provides a wide range of therapeutic products, including treatments for cardiovascular diseases, diabetes, infections, and gastrointestinal disorders. Operating as a contract development and manufacturing organization (CDMO), Heer Pharma offers services ranging from formulation development to large-scale production of tablets, capsules, and pellets. Their manufacturing facilities adhere to Good Manufacturing Practice (GMP) standards, enabling them to serve diverse international markets across Africa, Southeast Asia, and Latin America. The company is recognized for its expertise in pelletization technology and niche generic drug delivery systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Heer Pharma.